| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |